Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
University of Lorraine
Nancy, FranciaPublicacións en colaboración con investigadores/as de University of Lorraine (13)
2024
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Seminars in Arthritis and Rheumatism, Vol. 65
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56
-
Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review
Seminars in Arthritis and Rheumatism, Vol. 58
-
Fulminant myocarditis proven by early biopsy and outcomes
European Heart Journal, Vol. 44, Núm. 48, pp. 5110-5124
2022
-
Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD open, Vol. 8, Núm. 1
-
Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD open, Vol. 8, Núm. 1
2021
-
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116
2020
-
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171
-
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1378-1389
2016
2015
-
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 963-969